Literature DB >> 12875767

Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.

Su Min Chang1, Sherif F Nagueh, William H Spencer, Nasser M Lakkis.   

Abstract

OBJECTIVES: The purpose of this paper is to examine the incidence and determinants of permanent complete heart block (CHB) after nonsurgical septal reduction therapy (NSRT), and to evaluate the clinical impact of permanent pacemaker (PPM) placement.
BACKGROUND: Nonsurgical septal reduction therapy with ethanol improves the clinical and hemodynamic parameters in patients with symptomatic hypertrophic obstructive cardiomyopathy. Complete heart block is a common complication after NSRT.
METHODS: The database of 261 consecutive patients who underwent NSRT at Baylor College of Medicine was reviewed. Clinical variables that were considered as possible determinants for CHB after NSRT were: age, gender, New York Heart Association (NYHA) functional class, left ventricular outflow tract (LVOT) gradient at rest or with provocation, septal thickness, and baseline exercise duration. For electrocardiographic (ECG) variables, the presence of first-degree atrioventricular (AV) block, bifascicular block, left bundle branch block, atrial fibrillation, and left ventricular hypertrophy were analyzed. In addition, the volume of ethanol injected, the method of administration of ethanol (i.e., bolus vs. slow injection [over 30 to 60 s]), number of septal arteries occluded, use of myocardial echocardiography, and infarct size as determined by peak creatine kinase level.
RESULTS: Of 261 consecutive patients, 37 had PPM or automatic implantable cardiac defibrillator placed before NSRT. Of the remaining 224 patients, 31 (14%) developed CHB after the procedure. Multivariate logistic regression analysis showed that female gender (odds ratio [OR] 4.3; P = 0.02), bolus injection of ethanol (OR 51; P = 0.004), injecting more than one septal artery (OR 4.6; P = 0.016), the presence of left bundle branch block (OR 39; P = 0.002), and first-degree AV block (OR 14; P = 0.001) on the baseline ECG are independent predictors of CHB after NSRT. Patients requiring PPM placement had a similar improvement in their NYHA functional class, septal thickness reduction, LVOT gradient reduction, and improvement of exercise capacity when compared with patients who did not require pacing.
CONCLUSIONS: Multiple demographic, electrocardiographic, and technical factors seem to increase the risk of CHB after NSRT. Patients with CHB after NSRT derive similar clinical and hemodynamic benefit to patients who did not require permanent pacing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875767     DOI: 10.1016/s0735-1097(03)00623-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  A TASH experience: post-infarction myocardial oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation.

Authors:  D Basic; H Möllmann; M A Haas; A Rolf; A Jovanovic; Christoph Liebetrau; Sebastian Szardien; J Leick; Oliver Dörr; A Skwara; T Walther; C W Hamm; H M Nef
Journal:  Clin Res Cardiol       Date:  2011-12-27       Impact factor: 5.460

Review 2.  Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Authors:  Charles J Knight
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

3.  A case of ventricular asystole without escape rhythm 4 days after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy with drug-resistant paroxysmal atrial fibrillation.

Authors:  Mitsunori Ohtsubo; Hiroto Sakai; Hisashi Kon; Hideyuki Takano
Journal:  J Cardiol Cases       Date:  2011-08-11

4.  Surgical outcomes and strategy of hypertrophic obstructive cardiomyopathy.

Authors:  Ya-bin Zhu; S Rajan; V M Kurian; Zhi-yong Liu
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

5.  Therapeutic options in hypertrophic cardiomyopathy: a pediatric perspective.

Authors:  Edward K Rhee; John J Nigro; Stephen G Pophal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

Review 6.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2007

Review 7.  Intervention in HCM: patient selection, procedural approach and emerging techniques in alcohol septal ablation.

Authors:  Robert M Cooper; Adeel Shahzad; Rodney H Stables
Journal:  Echo Res Pract       Date:  2014-10-30

8.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Hicham El Masry; Jeffrey A Breall
Journal:  Curr Cardiol Rev       Date:  2008-08

Review 9.  Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Victor Arévalos; Juan José Rodríguez-Arias; Salvatore Brugaletta; Antonio Micari; Francesco Costa; Xavier Freixa; Mónica Masotti; Manel Sabaté; Ander Regueiro
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

10.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.

Authors:  I Sathyamurthy; Rajeshwari Nayak; Abraham Oomman; K Subramanyan; Mathew Samuel Kalarical; Robert Mao; P Ramachandran
Journal:  Indian Heart J       Date:  2013-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.